PA
ATRC icon

Perceptive Advisors’s AtriCure ATRC Stock Holding History

Perceptive Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-216,449
Closed -$8.64M – 142
2020
Q3 		$8.64M Sell
216,449
-312,327
-59% -$13.2M 0.13% 90
2020
Q2 		$23.8M Buy
528,776
+226,549
+75% +$9.86M 0.39% 54
2020
Q1 		$10.2M Buy
+302,227
New +$10.9M 0.26% 62
2017
Q2 		– Sell
-55
Closed -$1K – 136
2017
Q1 		$1K Sell
55
-94,345
-100% -$1.65M ﹤0.01% 161
2016
Q4 		$1.85M Buy
94,400
+86,451
+1,088% +$1.57M 0.13% 82
2016
Q3 		$126K Buy
+7,949
New +$122K 0.01% 175
2014
Q2 		– Sell
-100,000
Closed -$1.88M – 123
2014
Q1 		$1.88M Buy
+100,000
New +$2.05M 0.2% 68

Other funds holding ATRC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Perceptive Advisors's ATRC Position: Q4 2020 in Review

Perceptive Advisors sold out of AtriCure (ATRC) in Q4 2020, closing a stake of 216,449 shares — an estimated $8.64M sold.

Perceptive Advisors first reported a position in ATRC in Q1 2014 and held it in 7 quarters. The position peaked at $23.8M in Q2 2020. 198 funds tracked by Wall St. Rank hold ATRC as of Q4 2020.

  • Perceptive Advisors reported no remaining AtriCure position as of Q4 2020 after selling out during the quarter.
  • Perceptive Advisors sold 216,449 AtriCure shares in Q4 2020, an estimated $8.64M.
  • Perceptive Advisors first reported a position in AtriCure in Q1 2014 and held it in 7 quarters.
  • Perceptive Advisors's AtriCure position peaked at $23.8M in Q2 2020.
  • 198 funds tracked by Wall St. Rank held AtriCure as of Q4 2020.

Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.